Neoadjuvant chemotherapy for esophageal cancer: comparison of DCS (DTX/CDDP/S-1) chemotherapy with FAN (5-FU/ADM/Nedaplatin) chemotherapy

被引:0
|
作者
Shimoji, H. [1 ]
Nishimaki, T. [2 ]
Karimata, H. [1 ]
Hayasaka, K. [1 ]
机构
[1] Univ Ryukyus, Digest & Gen Surg, Nishihara, Okinawa, Japan
[2] Univ Ryukyus, Dept Surg, Fac Med, Nishihara, Okinawa, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-069
引用
收藏
页码:21 / 21
页数:1
相关论文
共 50 条
  • [21] Second-line combination chemotherapy of oral S-1 with cisplatin and irinotecan for colorectal cancer resistant to 5-FU
    Tsutsumi, S
    Yamaguchi, S
    Ide, M
    Tsuboi, K
    Fukasawa, T
    Yamaki, S
    Asao, T
    Kuwano, H
    [J]. HEPATO-GASTROENTEROLOGY, 2006, 53 (68) : 196 - 200
  • [22] Effects of biochemical modulation chemotherapy with CDDP and 5-FU on metastatic brain tumor from lung cancer
    Nakagawa, H
    Yamada, M
    Hagiwara, Y
    Kanayama, T
    Iwatsuki, K
    Moriuchi, S
    [J]. NEUROLOGICAL SURGERY, 1997, 25 (03): : 215 - 223
  • [23] Combination chemotherapy of S-1, docetaxel and CDDP for the treatment of advanced gastric cancer
    Niitsu, Yoshiro
    Takayama, Tetsuji
    Sato, Yasushi
    Sagawa, Tamotsu
    Abe, Seichiro
    Kato, Junji
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 313 - 314
  • [24] Chemotherapy with low dose CDDP and continuous 5-FU for the treatment of advanced gastric cancers
    Tsuji, A
    Morita, S
    Horimi, T
    Takasaki, M
    Takahashi, I
    Shirasaka, T
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 179 - 179
  • [25] S-1/CDDP/Lentinan combination chemotherapy for inoperable advanced gastric cancer
    Nagahashi, S
    Suzuki, H
    Hibi, T
    [J]. PROCEEDINGS OF THE 6TH INTERNATIONAL GASTRIC CANCER CONGRESS, 2005, : 155 - 161
  • [26] A comparison of dose and scheduling effect of 5-FU chemotherapy in advanced colorectal cancer
    O'Neill, PA
    Smith, DB
    Marshall, E
    Clark, PI
    O'Reilly, SM
    [J]. BRITISH JOURNAL OF CANCER, 2001, 85 : 44 - 44
  • [27] Induction Chemotherapy with Nedaplatin with 5-FU Followed by Intensity-modulated Radiotherapy Concurrent with Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma
    Zheng, Jijun
    Wang, Ge
    Yang, Gary Y.
    Wang, Daoyuan
    Luo, Xizhong
    Chen, Chuan
    Zhang, Zhimin
    Li, Qiong
    Xu, Wen
    Li, Zengpeng
    Wang, Dong
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (05) : 425 - 431
  • [28] Erratum to: Neoadjuvant chemotherapy using concurrent Docetaxel/CDDP/5-FU (DCF) in esophageal squamous cell carcinoma and its short-term prognosis
    Natsuya Katada
    Keishi Yamashita
    Chikatoshi Katada
    Hiromitsu Moriya
    Kei Hosoda
    Hiroaki Mieno
    Katsuhiko Higuchi
    Shoko Komori
    Hiromichi Ishiyama
    Kazushige Hayakawa
    Mitsuhiro Sugawara
    Satoshi Tanabe
    Wasaburo Koizumi
    Shiro Kikuchi
    Masahiko Watanabe
    [J]. Esophagus, 2014, 11 (3) : 182 - 182
  • [29] Neoadjuvant chemotherapy with S-1 plus cisplatin for esophageal squamous cell carcinoma
    Takamasa Takahashi
    Yuji Kaneoka
    Atsuyuki Maeda
    Yuichi Takayama
    Kazuaki Seita
    [J]. Updates in Surgery, 2022, 74 : 675 - 683
  • [30] Neoadjuvant chemotherapy with S-1 plus cisplatin for esophageal squamous cell carcinoma
    Takahashi, Takamasa
    Kaneoka, Yuji
    Maeda, Atsuyuki
    Takayama, Yuichi
    Seita, Kazuaki
    [J]. UPDATES IN SURGERY, 2022, 74 (02) : 675 - 683